No Picture
Trading Ideas

Boeing negotiation for Embraer's commercial division 'no longer helpful': CEO

Boeing, which is working to bring its 737 MAX jet back into service after two fatal crashes, canceled the $4.2 billion deal for the Brazilian company’s regional jet division over the weekend, prompting Embraer to initiate arbitration. “It is deeply disappointing, but we had reached a point where continued negotiation was no longer helpful,” Calhoun told the virtual meeting. Calhoun said Boeing expects it will take two to three years for travel to return to 2019 levels and an additional few years more for industry’s long-term trend growth to return. …read more […]

No Picture
Trading Ideas

2 5G Stocks to Consider as the Trend Heats Up

5G is here. The new digital wireless technology first started to make waves in 2017, with connectivity tests in Argentina, Norway, and Poland. By late 2018, active 5G networks were starting to appear on a limited basis in various urban areas, and in 2019 the first nationwide networks went into operation in the US and China. As 2020 matures, industry analysts expect to see these networks expand, as providers move into the mid- and high-frequency bands.The new network rollout brings with it a slew of opportunities, as does any new technology. Original equipment manufacturers will need new components. The new …read more […]

Healthcare

CytoDyn (OTC: CYDY) Announces Vyrologix as Proprietary Name for Leronlimab as a Combination Therapy for Highly Treatment Experienced HIV Patients in the United States

Company appoints Interim Chief Financial Officer VANCOUVER, Washington, Apr 27, 2020  — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for […]

Healthcare

CytoDyn (OTC: CYDY) Submits Completed Biologics License Application (BLA) to the FDA for Leronlimab as a Combination Therapy for Highly Treatment Experienced HIV Patients

VANCOUVER, Washington, Apr 27, 2020  — During the FDA’s review period, the Company will dedicate all resources to ensure availability of leronlimab for COVID-19 patients; Cancer programs continue with positive results VANCOUVER, Washington, April 27, 2020 […]

No Picture
Trading Ideas

Buffett and Abel, but not Munger, to field questions at Berkshire annual meeting

Berkshire said on Monday that Buffett, 89, and Vice Chairman Greg Abel, 57, will be physically present to answer shareholder questions at the afternoon meeting, but other directors including Munger and Vice Chairman Ajit Jain will be absent. The meeting is normally part of a weekend of festive events that draws more than 40,000 people to Omaha, Nebraska, where Berkshire is based, but the coronavirus pandemic forced Berkshire to scrap those events and keep shareholders away. …read more […]